Products are for professional/laboratory use only.
Swapping versus dose optimization in patients losing response to adalimumab with adequate drug levels. Roblin X, Genin C, Nancey S, Williet N, Veyrard P, Boschetti G, Phelip JM, Berger AE, Killian M, Waeckel L, Flourie B and Paul S. Inflammatory Bowel Diseases, 2021, Aug 18:izab158.
Products are for professional/laboratory use only.
TDM in Chronic Inflammatory Diseases (CID)
Biologic therapies, and notably Monoclonal antibodies (mAbs) and Fusion Proteins (FP), have revolutionised the management of CID, such as Inflammatory Bowel Disease, Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriasis and Psoriatic Arthritis that affect millions of people worldwide.
Products are for professional/laboratory use only.
Please find below a summary of the recently published British guidelines on the management of inflammatory bowel disease in adults.